9 March 2020
Washington power house lobbyist PhRMA says Malaysian patients should be prescribed the right medication for their conditions.
Tag: 2020 Special 301 Report
6 March 2020
PhRMA says medicine price ceilings may delay patient access to new treatments.
2 March 2020
The Pharmaceutical Research and Manufacturers of America wants the Trump administration to reverse compulsory licensing in Malaysia and end "discriminatory" market access practices.